Clinical Trials

Peer Reviewed News for Medical Professionals

Medical Research Health Special Topics World

Home

	Health
	Aging
	Asian Health
	Events
	Fitness
	Food & Nutrition
	Happiness
	Men's Health
	Mental Health
	Occupational Health
	Parenting
	Public Health
	Sleep Hygiene
	Women's Health

	Healthcare
	Africa
	Australia
	Canada Healthcare
	China Healthcare
	India Healthcare
	New Zealand
	South Africa
	UK
	USA
	World Healthcare

	Latest Research
	Aging
	Alternative Medicine
	Anaethesia
	Biochemistry
	Biotechnology
	Cancer
	Cardiology
	CAD
	CHF
	Clinical Trials
	Hypertension
	Myocardial Infarction
	Clinical Trials
	Cytology
	Dental
	Dermatology
	Embryology
	Endocrinology
	ENT
	Environment
	Epidemiology
	Gastroenterology
	Genetics
	Gynaecology
	Haematology
	Immunology
	Infectious Diseases
	Medicine
	Metabolism
	Microbiology
	Musculoskeletal
	Nephrology
	Neurosciences
	Obstetrics
	Ophthalmology
	Orthopedics
	Paediatrics
	Pathology
	Pharmacology
	Physiology
	Psychiatry
	Radiology
	Rheumatology
	Sports Medicine
	Surgery
	Toxicology
	Urology

	Medical News
	Awards & Prizes
	Epidemics
	Launch
	Opinion
	Professionals

	Special Topics
	Ethics
	Euthanasia
	Evolution
	Feature
	Odd Medical News
	Climate

Advanced Search

Latest Research : Cardiology : Clinical Trials
	Last Updated: Nov 1, 2009 - 11:48:48 PM

Latest Research : Cardiology : Clinical Trials
Aspirin of no use in primary prevention of cardiovascular events- POPADAD trial

In the BMJ this week, the results of the POPADAD (the prevention of progression of arterial disease and diabetes)trial were presented.The results of this study call for a change in the guidelines for the use of aspirin in high risk individuals with no existing cardiovascular disease.
Nov 1, 2008 - 2:33:34 AM

Latest Research : Cardiology : Clinical Trials
Adipose-derived stem cells as a therapy for cardiovascular diseases ?

Cytori Therapeutics (NASDAQ:CYTX) (FWB:XMPA) and Hospital Gregorio Maranon in Madrid, Spain treated the first patient in Cytori's randomized clinical trial investigating the safety and feasibility of adipose-derived stem and regenerative cells as a therapy for cardiovascular disease.
Feb 11, 2007 - 12:45:32 PM

Latest Research : Cardiology : Clinical Trials
Pre hypertension best managed by early pharmacological intervention

Patients experiencing high normal blood pressure (HNBP), a precursor to hypertension, may benefit from early treatment with pharmacological therapy, according to new research presented today at the American College of Cardiology's 55th Annual Scientific Session. HNBP, often referred to as "prehypertension," is associated with double the normal risk of heart attacks and strokes. ACC.06 is the premier cardiovascular medical meeting, bringing together more than 30,000 cardiologists to further breakthroughs in cardiovascular medicine.
Mar 19, 2006 - 2:42:37 AM

Latest Research : Cardiology : Clinical Trials
Patients should not discontinue clopidogrel without consultation

Recent media reports regarding the results of the CHARISMA Trial may be misinterpreted by patients with coronary stents and other conditions*, causing these patients to inappropriately stop taking the anti-clotting drug clopidogrel (Plavix®). Patients taking Plavix® for any reason should consult with their cardiologist or other health care provider before stopping this medication.
Mar 18, 2006 - 2:39:37 AM

Latest Research : Cardiology : Clinical Trials
Clopidogrel and aspirin combination fails to show long term beneficial affects in stable vascular patients

While the CHARISMA trial (Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance) results have shown no benefit overall of the combination of Clopidogrel and aspirin in the long term in stable vascular patients, and some indication of harm in patients in primary prevention, the ESC would like to remind patients that dual antiplatelet therapy is an essential, approved and recommended therapy for one year in patients post ACS without ST-segment elevation, and for at least six months post stenting.
Mar 18, 2006 - 2:16:37 AM

Latest Research : Cardiology : Clinical Trials
Bluhm Cardiovascular Institute Surgeons Implant Heart Pump in Comparative Study of Two Devices

Chicago's first participant in the RELIANT (Randomized Evaluation of the Novacor(r) LVAS In A Non-Transplant Population) research study recently went home from Northwestern Memorial Hospital.
Nov 19, 2005 - 2:00:38 AM

Latest Research : Cardiology : Clinical Trials
Ground-breaking heart stem cell trial (REGENERATE) now underway

Doctors at Barts and The London NHS Trust have launched the UKs first large-scale clinical trial designed to find out if a patients own stem cells can be used to treat heart disease. The ground-breaking research, which is being funded by the Heart Cells Foundation charity, will involve 700 patients over the next four years. The trial is made up of three randomised-controlled studies. The first study will involve 300 patients whose hearts are failing because of heart disease or a previous heart attack. The second study will involve 200 patients whose hearts are failing specifically because of dilated cardiomyopathy a heart muscle disorder. The third study will involve 200 patients who have just had a heart attack.
Oct 13, 2005 - 3:24:38 PM

<< prev next >>